EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

M.I.TECH Co.Ltd (179290) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of M.I.TECH Co.Ltd KRW 9,272, price KRW 4,520, upside +105.1%, quality 70 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · KR · ISIN KR7179290002

MI Some data Sep 24, 2026

M.I.TECH Co.Ltd

179290 · KQ

Clearly undervaluedStrong Fair Value upside, but quality is only moderate.

✓Fair value 9,272 KRW · Strongly undervalued (+105%)
✓Quality 70/100
!Mixed Growth (revenue 5y +10.8 %/yr)
✓Highly profitable · 29.1% net margin (TTM)
✓Low debt · generates free cash flow
·2.65% dividend yield
✓Ranks above peers (9/10)
✓Wide moat 77/100
!Evidence only medium, so the estimate is less certain

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

15,151 KRW 4,049 KRW Fair Value 9,272 KRW Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 4,049 KRW – 15,151 KRW · fair‑value band 5,444 KRW – 13,757 KRW · the 4,520 KRW price screens below the 9,272 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow M.I.TECH Co.Ltd in your weekly email

Every Wednesday you see whether M.I.TECH Co.Ltd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

M.I.TECH Co.,Ltd engages in the provision of various medical devices in South Korea. The company offers HANAROSTENT, a non-vascular stent; and glucometers under the GBIO BASE and RAPICHECK brand names.

Show more

M.I.TECH Co.,Ltd engages in the provision of various medical devices in South Korea. The company offers HANAROSTENT, a non-vascular stent; and glucometers under the GBIO BASE and RAPICHECK brand names. It also provides beauty systems, such as BRT system which is used in cleansing skin and inject the effective component in non-invasive way; and ClearView which is used in injecting the effective component in non-invasive way and instantly check skin condition before and after treatment. The company was formerly known as Solco Intermed Co., Ltd. and changed its name to M.I.TECH Co.,Ltd in March 1999. M.I.TECH Co.,Ltd was founded in 1991 and is headquartered in Pyeongtaek-Si, South Korea. M.I.TECH Co.,Ltd operates as a subsidiary of Synergy Innovation Co., Ltd.

Stock analysis

M.I.TECH Co.Ltd (179290) currently trades at 4,520 KRW, while our model-based Fair Value estimate is 9,272 KRW, implying the stock looks roughly 51.3% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 14,604 KRW per share, and 22 of the 24 models we run sit above the 4,520 KRW price.

Bear case: the Asset-Based group reads lowest at 2,607 KRW, and 2 of the 24 models stay below the price. Evidence for this calculation is medium.

Scenario range: 5,444 KRW (bear) to 13,757 KRW (bull), the price of 4,520 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 70/100 (solid quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

M.I.TECH Co.Ltd reported revenue of 67.2B KRW in FY2025 versus 50.3B KRW in FY2021, a compound +7.5%/yr. Reported net income was 20.3B KRW in FY2025, compounding +13.5%/yr from FY2021.

Key figures

Market cap 146B KRW (≈ $108M) · P/S ratio 2.19 · Dividend yield 2.7% · Net margin 30.3% · Return on equity 16.4% · Return on assets (EBIT) 16.8% · Operating margin 29.4% · Revenue (TTM) 66.6B KRW.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).

What moves the price

The share trades about 42% below its 52-week high and 8% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −13% fair-value upside, at 105%, 179290 screens cheaper than that median.

Fair Value models

Bear 5,444 KRW Fair Value 9,272 KRW Bull 13,757 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 4,339 KRW 6,404 KRW 10,149 KRW 79
Growth DCF 4,241 KRW 6,244 KRW 8,818 KRW 78
Owner Earnings 6,797 KRW 10,863 KRW 17,191 KRW 75
All 24 models by family
DCF Models
FCF DCF 4,339 KRW 6,404 KRW 10,149 KRW 79
Owner Earnings 6,797 KRW 10,863 KRW 17,191 KRW 75
5Y Revenue Exit 5,059 KRW 8,416 KRW 13,161 KRW 71
5Y EBITDA Exit 6,660 KRW 11,903 KRW 18,813 KRW 73
5Y P/E Exit 8,260 KRW 15,386 KRW 24,014 KRW 69
10Y Revenue Exit 4,581 KRW 7,416 KRW 12,093 KRW 65
10Y EBITDA Exit 5,628 KRW 9,670 KRW 16,358 KRW 66
10Y P/E Exit 6,558 KRW 11,922 KRW 20,283 KRW 62
Earnings-Based
Graham-Dodd 4,272 KRW 23,786 KRW 33,024 KRW 63
Lynch FV 6,645 KRW 9,493 KRW 12,341 KRW 61
PEG = 1.0 6,645 KRW 9,493 KRW 12,341 KRW 57
EPV 5,332 KRW 5,825 KRW 6,225 KRW 74
Multiples
P/E Multiple 10,366 KRW 13,822 KRW 17,277 KRW 63
P/S Multiple 5,446 KRW 7,262 KRW 9,077 KRW 58
P/B Multiple 8,010 KRW 10,680 KRW 13,351 KRW 55
EV/EBIT 9,370 KRW 12,085 KRW 14,800 KRW 66
EV/EBITDA 8,744 KRW 11,251 KRW 13,757 KRW 67
EV/Revenue 5,583 KRW 7,450 KRW 9,318 KRW 54
Asset-Based
NCAV (Graham) 1,945 KRW 2,607 KRW 3,891 KRW 54
Growth DCF
Growth DCF 4,241 KRW 6,244 KRW 8,818 KRW 78
Rev-Margin DCF 5,059 KRW 8,280 KRW 12,694 KRW 71
Economic Profit
Residual Income 3,596 KRW 4,367 KRW 8,881 KRW 72
ROIC Compounder 5,803 KRW 7,048 KRW 8,575 KRW 72
Growth Earnings
Growth-Adj P/E 10,223 KRW 14,604 KRW 18,985 KRW 67

Open the full fair value analysis →

Notify me when 179290 reaches fair value

Put 179290 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 70/100

Of which business quality 68 · Market factors (momentum, volatility) 30

Profitability 64
Margins and returns on capital today
Quality Growth 60
Are margins and returns improving?
Cashflow 53
Earnings quality: real cash, not paper profit
Fin. Strength 99
Balance sheet, leverage, solvency risk
Investment 41
Disciplined investing over empire-building
Low Volatility 69
Calm price path (market factor)
Momentum 19
Price trend over the last 3–12 months (market factor)
52W Momentum 5
Distance to the 52-week high (market factor)
Net Issuance 80
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 84/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+24.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.8%
Start year 2020 (pandemic). Over 10 years: +18.2% a year
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.2%
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+26.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year+24.0%
Dividend (yield on the price)2.7%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.24% vs 22%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.15% → 31%
Start year 2020 (pandemic)

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−1.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about −3.3% a year for the price.

Watch 179290, get fair value alerts →

Compare M.I.TECH Co.Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 204 stocks

Beats the industry median on 8/9 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 70 · Top 25%
Fair Value upside +105% · Top 25%
Profitability
Return on equity (TTM) 16% · Top 25%
Return on assets 10% · Top 25%
Net margin (TTM) 29% · Top 25%
Operating margin (TTM) 29% · Top 25%
Growth and dividend
Revenue growth −3% · Bottom 25%
Dividend yield (TTM) 2.7% · Above median

Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper

P/FCF 0.0× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 14
FUTURE (revenue growth)0 · sector 31
PAST (return on equity)66 · sector 25
HEALTH (low debt)100 · sector 96
DIVIDEND (yield)53 · sector 33

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Intuitive Surgical, Inc ISRG $399.52 $348.72 −13%
EssilorLuxottica Société anonyme EL €144.70 €159.17 +10%
Medline Inc MDLN $34.30 $30.15 −12%
Becton, Dickinson and Company BDX $182.52 $103.53 −43%
Alcon Inc ALC $65.39 $39.78 −39%
ResMed Inc RMD A$31.70 A$34.87 +10%
West Pharmaceutical Services, Inc WST $375.87 $137.28 −63%
Sartorius Stedim Biotech S.A DIM €215.80 €54.82 −75%
Straumann Holding STMN CHF 96.38 CHF 45.50 −53%
Solventum Corporation SOLV $88.75 $130.51 +47%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "M.I.TECH Co.Ltd Fair Value". https://www.fairvalue-calculator.com/stock/179290

Frequently asked questions

Is M.I.TECH Co.Ltd (179290) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 9,272 KRW versus a price of 4,520 KRW, about +105% upside (undervalued).
What is the fair value of 179290?
Our model-based fair value for M.I.TECH Co.Ltd is 9,272 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 4,520 KRW.
What is the quality score of 179290?
M.I.TECH Co.Ltd has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for M.I.TECH Co.Ltd (179290)?
Our model-based price target is the fair value of 9,272 KRW (as of Sep 24, 2026) from 24 valuation models. Cautious scenario 5,444 KRW, optimistic scenario 13,757 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the M.I.TECH Co.Ltd stock forecast for 2026?
Our models put fair value at 9,272 KRW, about +105% upside versus a price of 4,520 KRW (undervalued). Cautious scenario 5,444 KRW, optimistic scenario 13,757 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of M.I.TECH Co.Ltd (179290)?
M.I.TECH Co.Ltd reported trailing-twelve-month revenue of about 66.6B KRW (latest available figure, as of Sep 24, 2026).
Does M.I.TECH Co.Ltd pay a dividend?
M.I.TECH Co.Ltd currently shows a dividend yield of about 2.65% relative to its recent price (as of Sep 24, 2026).
What growth is priced into M.I.TECH Co.Ltd (179290)?
For today's price to be fair in a discounted-cash-flow model, M.I.TECH Co.Ltd would have to grow free cash flow by -1.2 % per year for five years (discount rate 13.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +10.8 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 179290 use?
Our models discount M.I.TECH Co.Ltd at 13.1 %: a base by market capitalisation (micro), country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For M.I.TECH Co.Ltd that is -1.2 % per year a year over ten years, using the same discount rate (13.1 %) and the same formula as our fair value.
How much growth has M.I.TECH Co.Ltd (179290) delivered so far?
Over the past 5 years revenue at M.I.TECH Co.Ltd grew +10.8 % a year. The price currently implies -1.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of M.I.TECH Co.Ltd (179290) growing?
The median revenue growth in the sector is +1.9 % a year. That is the yardstick for the growth priced into M.I.TECH Co.Ltd (-1.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of M.I.TECH Co.Ltd (179290)?
The free-cash-flow yield on the price is 6.78 %: that much free cash flow M.I.TECH Co.Ltd produces per unit of market value. When it exceeds the discount rate of our models (13.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of M.I.TECH Co.Ltd (179290)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For M.I.TECH Co.Ltd it is 9,272 KRW per share (as of Sep 24, 2026), against a price of 4,520 KRW. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is M.I.TECH Co.Ltd stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 179290 trades below its calculated fair value: price 4,520 KRW, fair value 9,272 KRW, a gap of about +105% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 179290?
No. The price is what the market pays today (4,520 KRW); the fair value is what the company's own numbers justify (9,272 KRW). For M.I.TECH Co.Ltd the two are 4,752 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is M.I.TECH Co.Ltd worth?
The market values M.I.TECH Co.Ltd at about 146B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 4,520 KRW; our models calculate a fair value of 9,272 KRW per share.
What do the bullish and bearish scenarios say about 179290?
Our models span a range for M.I.TECH Co.Ltd: cautious scenario 5,444 KRW, base 9,272 KRW, optimistic 13,757 KRW per share (as of Sep 24, 2026, price 4,520 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of M.I.TECH Co.Ltd (179290)?
Balance-sheet figures for M.I.TECH Co.Ltd (as of Sep 24, 2026): return on equity 16.4%. They feed the Quality Score of 70/100, which measures business quality independently of the share price.
How far is 179290 from its 52-week high?
M.I.TECH Co.Ltd trades at 4,520 KRW, about 42% below its 52-week high of 7,810 KRW and 8% above the low of 4,195 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 9,272 KRW is for.
Which stocks are comparable to M.I.TECH Co.Ltd?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Medline Inc, Becton, Dickinson and Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is M.I.TECH Co.Ltd stock attractive at the current price?
The data as of Sep 24, 2026: price 4,520 KRW, calculated fair value 9,272 KRW (+105%), Quality Score 70/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 179290 calculated?
We run M.I.TECH Co.Ltd through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 9,272 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. M.I.TECH Co.Ltd currently trades 105 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of M.I.TECH Co.Ltd (179290)?
The closing price on Sep 23, 2026 was 4,520 KRW. Our model-based fair value is 9,272 KRW, about +105% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with M.I.TECH Co.Ltd right now?
The rarer combination: high quality (70/100) AND below fair value. That earns a closer look rather than a quick verdict. The price is below even our cautious bear case (5,444 KRW). The market is more pessimistic than our downside scenario. A fairly wide model range (5,444 KRW to 13,757 KRW) leaves room in how you read the outcome.

Key figures of M.I.TECH Co.Ltd

How large is the market capitalisation of M.I.TECH Co.Ltd (179290)?
The market capitalisation of M.I.TECH Co.Ltd is 146B KRW (≈ $108M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of M.I.TECH Co.Ltd (179290)?
The price-to-sales ratio of M.I.TECH Co.Ltd is 2.19 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of M.I.TECH Co.Ltd (179290)?
The dividend yield of M.I.TECH Co.Ltd is 2.7%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of M.I.TECH Co.Ltd (179290)?
The net margin of M.I.TECH Co.Ltd is 30.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of M.I.TECH Co.Ltd (179290)?
The return on equity (ROE) of M.I.TECH Co.Ltd is 16.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of M.I.TECH Co.Ltd (179290)?
On an EBIT basis the return on assets of M.I.TECH Co.Ltd is 16.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of M.I.TECH Co.Ltd (179290)?
The operating margin of M.I.TECH Co.Ltd is 29.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at M.I.TECH Co.Ltd (179290)?
Revenue at M.I.TECH Co.Ltd is growing −3.0% versus a year earlier (3y avg +6.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at M.I.TECH Co.Ltd (179290)?
Earnings per share at M.I.TECH Co.Ltd are growing −16.8% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Watch M.I.TECH Co.Ltd in the live analysis

One click puts M.I.TECH Co.Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.